Various abnormalities in metabolism of water and electrolytes have been noted in patients with arterial hypertension and have variously been considered as causes or results of the hypertension. In this paper new data on these relationships are presented by a study of the changes in renal function produced by intravenous hydration, Pitressin, and lowering of the blood pressure. In the present study of water excretion in essential hypertension a disturbance is described that appears in part to be related to the elevation of arterial pressure.
A NUMBER of workers have shown that the capacity to excrete sodium, as indicated by the rate of excretion of an intravenous salt load, is appreciably greater in hypertensive than in normotensive individuals. [1] [2] [3] In addition, it has been demonstrated that effective antihypertensive treatment is capable of reducing the sodium excretory capacity of hypertensive subjects towards normal. 4' 5 These findings support the concept that the arterial pressure per se may play an important role in the control of sodium excretion. They also suggest that certain other disturbances in electrolyte and water metabolism in arterial hypertension6 may be the result and not necessarily the cause of an elevated blood pressure.
In the present study of water excretion in essential hypertension a disturbance is de- scribed that appears in part to be related to the elevation of arterial pressure.
MATERIAL AND METHODS
The renal responses to intravenous hydration and Pitressin were tested in 11 hypertensive and 9 control subjects. In addition, 9 of the hypertensive subjects were restudied after treatment with antihypertensive drugs.
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The 11 subjects with essential hypertension had a sustained elevation of the blood pressure with grade 1 to 3 retinopathy but without complicating congestive heart failure. However, 4 subjects had electrocardiographic and roentgenologic evidence of left ventricular enlargement as well as 1+ to 2+ ailbuminuria. In addition 3 of these subjects had an elevation of the blood urea nitrogen ranging from 35 to 84 mg. per cent. The dietary intake of salt was not restricted in either the hypertensive or normotensive subjects.
After an 8 to 12-week control period during which the hypertensive subjects received only placebos, treatment was started with antihypertensive drugs and continued for 8 to 16 weeks. The type and dosage of drugs together with their effects on blood pressure are summarized in table 1. The blood pressures were measured weekly in the sitting position. The control urine flows were comparable iii the normotensive and hypertensive groups. However, the maximal diuresis produced by the infusion of 5 per cent glucose and water was appreciably lower in the hypertensive than in the normotensive group. These differences were significant even though the 3 hypertensive subjects who had advanced renal disease were not included in the statistical analysis of the groups. The time at which urine flow reached its peak level was not sigimificantly different in the control and hypertensive groups. Likewise the percentage reduction in urine flow and the duration of the antidiuresis produced by Pitressin did not differ significantly in the groups. In the recovery period the average urine flow was lower, but not significantly, in the hypertensive than in the normotensive group.
When compared with normotensive and hypertensive subjects without advanced renal disease, hypertensive subjects with severe renal disease had a considerable reduction in the maximal water diuresis and appeared to be unresponsive to Pitressin.
Following antihypertensive drug treatment, the average maximal rate of urine excretion in the hypertensive group significantly inicreased to 13.6 ml. per minute as compared 
DISCUSSION
The observation that the maximal rate of urine flow produced by intravenous hydration was significantly less in hypertensive than in normotensive individuals suggests a reduction in water excretory capacity in arterial hypertension. The disturbance in water excretion was associated with a significant reduction in glomerular filtration rate and was most marked in those hypertensive subjects who had the severest impairment in this function. It therefore appears likely that a reduction in glomerular filtration rate is one of the factors responsible for the reduced water diuresis. Solute excretion also has been reported to be capable of altering the height of a water diuresis.7' 8 Although it was not measured, sodium and potassium excretion, which contributes to solute excretion, appeared to be comparable in the normotensive and the treated and untreated hypertensive subjects. In addition to a reduction in renal hemodynamic function, an elevated blood pressure appears to be another important factor that might operate to reduce maximal urine flow, since a significant increase in water diuresis occurred without a change in glomerular filtration rate following a reduction in blood pressure with antihypertensive drugs. It is unlikely that the increases in urine flow following treatment were due to a direct drug effect on renal function, since the same effects were produced by several different drug regimens.
The 
